mrmarket.ai
Stock Overview

Teva Pharma Industries Ltd ADR (TEVA)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Teva Pharma Industries Ltd ADR is a Healthcare company with a market capitalization of $38.67B and a trailing P/E ratio of 24.8.

Market Cap
$38.67B
P/E (TTM)
24.8
Forward P/E
16.0
Price/Sales
2.2
Price/Book
4.7
EV/EBITDA
16.3
Beta
0.85
EPS (TTM)
$1.34
Profit Margin
9.0%
ROE
21.6%
52W High
$37.35
52W Low
$14.99

5-Year Price History

Latest Annual Financials · FY ending December 31, 2025

Revenue
$17.26B
Gross Profit
$8.94B
Operating Income
$2.16B
Net Income
$1.41B
Free Cash Flow
$1.15B
Total Debt
$16.81B
Cash & Equivalents
$3.56B
Shareholder Equity
$7.91B

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q1 2026April 29, 2026$0.53$0.46+15.2%
Q4 2025January 28, 2026$0.41$0.20+105.0%
Q3 2025November 5, 2025$0.78$0.67+16.4%
Q2 2025July 30, 2025$0.66$0.62+6.5%
Q1 2025May 7, 2025$0.52$0.46+13.0%
Q4 2024January 29, 2025$0.71$0.70+1.4%

Other Drug Manufacturers - Specialty & Generic Stocks

TAK
Takeda Pharmaceutical Co Ltd ADR
$50.27B
HLN
Haleon plc
$40.72B
ZTS
Zoetis Inc
$31.90B
UTHR
United Therapeutics Corporation
$23.03B
VTRS
Viatris Inc
$19.02B
NBIX
Neurocrine Biosciences Inc
$16.94B
RDY
Dr. Reddy’s Laboratories Ltd ADR
$12.81B
ELAN
Elanco Animal Health
$12.27B
TEVA vs TAKTEVA vs HLNTEVA vs ZTS

Frequently Asked Questions

What is Teva Pharma Industries Ltd ADR's market cap?

As of June 29, 2026, Teva Pharma Industries Ltd ADR (TEVA) has a market capitalization of $38.67B.

What is Teva Pharma Industries Ltd ADR's P/E ratio?

Teva Pharma Industries Ltd ADR trades at a trailing price-to-earnings (P/E) ratio of 24.8. Its forward P/E is 16.0.

Does Teva Pharma Industries Ltd ADR pay a dividend?

Teva Pharma Industries Ltd ADR does not currently pay a dividend.

What sector is TEVA in?

Teva Pharma Industries Ltd ADR is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.

What was Teva Pharma Industries Ltd ADR's revenue?

In its latest reported fiscal year (ending December 31, 2025), Teva Pharma Industries Ltd ADR reported revenue of $17.26B and net income of $1.41B.

Ask your own questions about TEVA

Try mrmarket.ai free

Data as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.